|
ZNF519 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.27284857601262E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.71274147379108E-12 |
| Normal-vs-Stage2 |
3.097100E-03 |
| Normal-vs-Stage3 |
2.34429999967922E-07 |
| Normal-vs-Stage4 |
1.60684999999106E-05 |
| Stage1-vs-Stage2 |
2.932400E-01 |
| Stage1-vs-Stage3 |
3.774200E-01 |
| Stage1-vs-Stage4 |
3.812000E-01 |
| Stage2-vs-Stage3 |
6.940600E-01 |
| Stage2-vs-Stage4 |
7.746800E-01 |
| Stage3-vs-Stage4 |
9.188600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.69002655892837E-13 |
| Normal-vs-AfricanAmerican |
6.044600E-03 |
| Normal-vs-Asian |
1.607560E-02 |
| Caucasian-vs-AfricanAmerican |
1.200000E-01 |
| Caucasian-vs-Asian |
7.726600E-01 |
| AfricanAmerican-vs-Asian |
7.401400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.03320044028987E-10 |
| Normal-vs-Female |
1.81720194447621E-11 |
| Male-vs-Female |
1.250990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.299800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.21369581052022E-11 |
| Normal-vs-Age(61-80Yrs) |
1.33209998587347E-09 |
| Normal-vs-Age(81-100Yrs) |
1.003970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.281600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.752000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.929200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.475400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.184180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.386400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.43050000001033E-06 |
| Normal-vs-Grade 2 |
6.0196292395176E-13 |
| Normal-vs-Grade 3 |
1.65689995057505E-09 |
| Normal-vs-Grade 4 |
1.388050E-02 |
| Grade 1-vs-Grade 2 |
6.051800E-01 |
| Grade 1-vs-Grade 3 |
2.651200E-01 |
| Grade 1-vs-Grade 4 |
1.140400E-02 |
| Grade 2-vs-Grade 3 |
1.390390E-01 |
| Grade 2-vs-Grade 4 |
1.563380E-04 |
| Grade 3-vs-Grade 4 |
1.500180E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.93819999999767E-05 |
| ccA subtype-vs-ccB subtype |
1.80378999999897E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.24229959652666E-10 |
| Normal-vs-N1 |
2.904200E-03 |
| N0-vs-N1 |
6.084400E-01 |
|
|
